GUGGENHEIM CAPITAL LLC - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 127 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$437,000
-62.7%
7,692
-43.8%
0.00%
-62.5%
Q3 2018$1,171,000
-9.2%
13,699
+23.2%
0.01%
-11.1%
Q2 2018$1,290,000
-70.0%
11,123
-79.1%
0.01%
-18.2%
Q1 2018$4,306,000
+38.0%
53,219
+0.1%
0.01%
+57.1%
Q4 2017$3,120,000
+140.6%
53,176
+91.5%
0.01%
+133.3%
Q3 2017$1,297,000
+37.7%
27,763
+6.1%
0.00%
+50.0%
Q2 2017$942,000
+11.1%
26,158
-5.1%
0.00%0.0%
Q1 2017$848,000
-17.2%
27,560
-9.8%
0.00%
-33.3%
Q4 2016$1,024,000
+26.6%
30,550
-16.8%
0.00%0.0%
Q2 2016$809,000
-12.8%
36,718
+16.2%
0.00%0.0%
Q1 2016$928,000
+42.8%
31,600
+60.6%
0.00%
+50.0%
Q4 2015$650,000
-64.6%
19,681
-61.3%
0.00%
-66.7%
Q3 2015$1,836,000
+7.2%
50,803
+33.5%
0.01%
+50.0%
Q2 2015$1,712,000
+23.7%
38,063
-15.8%
0.00%
+33.3%
Q1 2015$1,384,000
-32.5%
45,195
+12.1%
0.00%
-40.0%
Q4 2014$2,051,000
-74.8%
40,326
-80.4%
0.01%
-73.7%
Q3 2014$8,128,000
+1346.3%
205,388
+1517.6%
0.02%
+1800.0%
Q2 2014$562,00012,6970.00%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 1,055,719$35,367,00012.68%
GREAT POINT PARTNERS LLC 828,253$27,746,0005.70%
McClain Value Management LLC 116,153$3,891,0004.80%
Stonepine Capital Management, LLC 231,913$7,769,0004.63%
ARMISTICE CAPITAL, LLC 228,000$7,638,0001.81%
Opaleye Management Inc. 90,000$3,015,0001.78%
Matarin Capital Management, LLC 257,268$8,618,478,0000.97%
HAYS ADVISORY LLC 116,939$3,917,0000.87%
Granahan Investment Management 496,025$16,617,0000.57%
AlphaMark Advisors, LLC 33,000$1,106,0000.57%
View complete list of ENANTA PHARMACEUTICALS INC shareholders